Viewing Study NCT01265927


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-01-22 @ 2:58 PM
Study NCT ID: NCT01265927
Status: COMPLETED
Last Update Posted: 2015-10-27
First Post: 2010-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Sponsor: Indiana University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module